Craft

Advanced
Biotest

Biotest

Stock Price

€41.6

2024-10-29

Market Capitalization

€1.3 B

2024-08-26

Revenue

€648.9 M

FY, 2025

Biotest Summary

Company Summary

Overview
Biotest is a company that specializes in the fields of clinical immunology, haematology as well as intensive care and emergency medicine. It develops, manufactures, and markets plasma proteins and biotherapeutic drugs.
Type
Public
Status
Active
Founded
1946
HQ
Dreieich, DE | view all locations
Website
https://www.biotest.com/de/en/index.cfm
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Silvio Audisio

    Silvio Audisio, Managing Director Italy Head of East and South Europe

    • Cathrin Schleussner, Chairwoman

      Operating MetricsView all

      Projects in R&D Pipeline

      8

      FY, 2016

      Phase III Trials Products

      3

      FY, 2016

      LocationsView all

      1 location detected

      • Dreieich, HE HQ

        Germany

        Landsteinerstraße 5

      Biotest Financials

      Summary Financials

      Revenue (FY, 2025)
      €648.9M
      Gross profit (FY, 2025)
      €142.7M
      Net income (FY, 2025)
      (€70.7M)
      Cash (FY, 2025)
      €89.8M
      EBIT (FY, 2025)
      (€47.4M)
      Enterprise value
      $2.0B

      Competitors and Similar Companies

      Compare competitors

      Footer menu

      Product

      Solutions

      Resources

      Company

      © Craft.co 2026
      Share price data provided by IEX